Suppression of HIV-1 transcription and replication by a Vpr mutant

Gene Therapy

Volumn 6, Issue 5, 1999, Pages 947-950

  Sawaya, B E ^a   Khalili, K ^a   Rappaport, J ^a   Serio, D ^b   Chen, W ^a   Srinivasan, A ^b   Amini, S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

HIV 1; Transcription; Vpr

Indexed keywords

ANTIGEN P24; ARGININE; ISOLEUCINE; LEUCINE; MUTANT PROTEIN; REGULATOR PROTEIN; SERINE; TRANSACTIVATOR PROTEIN; VPR PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; ASTROCYTE; CARBOXY TERMINAL SEQUENCE; GENE REPLICATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN STRUCTURE; T LYMPHOCYTE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AMINO ACID SUBSTITUTION; ASTROCYTES; CELLS, CULTURED; GENE PRODUCTS, VPR; GENE THERAPY; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033019869     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300907     Document Type: Article

References (16)

1. Cohen EA, Dehni G, Sodroski JG, Haseltine WA. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 1990; 64: 3097-3099.
2. Cohen EA et al. Identification of HIV-1 vpr product and function. J Acq Immun Def Syn 1990; 3: 11-18.
3. Sawaya BE et al. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 1998; 273: 20052-20057.
4. Mahalingam S et al. Mutagenesis of the putative alpha-helix domain of the Vpr protein of human immunodeficiency virus type-1: effect on stability and virion incorporation. Proc Natl Acad Sci USA 1995; 92: 3794-3798.
5. Mahalingam S et al. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 1995; 207: 297-302.
6. Mahalingam S, Patel M, Collman RG, Srinivasan A. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. Virology 1995; 214: 647-652.
7. Yao, XJ et al. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol 1995; 69: 7032-7044.
8. Mahalingam S, Srinivasan A. Structure-function studies of HIV-1 Vpr. 1995 Retroviruses Meeting. Cold Spring Harbor: New York, 1995, p 315, 25-30.
9. Refaeli Y, Levy DN, Weiner DB. The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product. Proc Natl Acad Sci USA 1995; 92: 3621-3625.
10. Wang L et al. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 1995; 270: 25564-25569.
11. Mahalingam S et al. Nuclear import, virion incorporation and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol 1997; 71: 6339-6347.
12. Felzien LK et al. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc Natl Acad Sci USA 1998; 95: 5281-5286.
13. Gaynor RB. Regulation of HIV-1 gene expression by the trans-activator protein Tat. Curr Top Microbiol Immunol 1995; 193: 51-77.
14. Di Marzio P et al. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 1995; 69: 7909-7916.
15. Graham FL, van der Eb A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-457.
16. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell Biol 1982; 2: 1044-1051.